ArticleAntimicrobial agents and chemotherapy2016

Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model.

Brian D VanScoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.